Window of Opportunity Clinical Trials
Showing 1 - 25 of >10,000
Renal Cell Cancer Trial in Cambridge (Olaparib, Cediranib, Durvalumab)
Recruiting
- Renal Cell Cancer
- Olaparib
- +2 more
-
Cambridge, England, United KingdomAddenbrooke's Hospital
May 21, 2021
Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)
Not yet recruiting
- Breast Cancer
- Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
-
Ottawa, Ontario, Canada
- +1 more
Jul 22, 2023
Breast Cancer Trial (GSK3326595)
Completed
- Breast Cancer
-
London, Ontario, CanadaSt. Joseph's Health Care London
Oct 24, 2022
Prostate Cancer Trial in Norwich (Allin, Sulforaphane, Placebo)
Completed
- Prostate Cancer
- Allin
- +2 more
-
Norwich, Norfolk, United KingdomQuadram Institute Bioscience
Nov 17, 2020
Primary Brain Tumor, Brain Tumor, Recurrent Trial in Durham (Fluoxetine, Temozolomide)
Not yet recruiting
- Primary Brain Tumor
- Brain Tumor, Recurrent
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Dec 20, 2022
Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)
Active, not recruiting
- Head and Neck Cancer
- Head and Neck Neoplasms
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Oral Cancer Trial in Charleston (Imiquimod 5% Cream,Top,Pkt,0.25Gm)
Recruiting
- Oral Cancer
- Imiquimod 5% Cream,Top,Pkt,0.25Gm
-
Charleston, South CarolinaMedical University of South Carolina
May 10, 2022
Breast Cancer Trial in Ottawa (INT230-6, Saline injection)
Recruiting
- Breast Cancer
- INT230-6
- Saline injection
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Research Institute and Cancer Center
Nov 9, 2021
Triple Negative Breast Cancer Trial in Lausanne (stereotactic body radiotherapy, CMP-001)
Recruiting
- Triple Negative Breast Cancer
- stereotactic body radiotherapy
- CMP-001
-
Lausanne, Vaud, SwitzerlandCHUV Oncology Department
Jul 6, 2021
Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma Trial in Houston (Cord Blood-derived
Not yet recruiting
- Recurrent Gliosarcoma
- +2 more
- Cord Blood-derived Expanded Allogeneic Natural Killer Cells
- Resection
-
Houston, TexasM D Anderson Cancer Center
May 24, 2022
HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer Trial in Milwaukee (HB-201 IT, HB-201 IV)
Recruiting
- HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
- HB-201 IT
- HB-201 IV
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jul 28, 2022
Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)
Not yet recruiting
- Undifferentiated Pleomorphic Sarcoma
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Nov 1, 2023
Colorectal Carcinoma (CRC), Endometrial Carcinoma (EC) Trial in Oklahoma City (TPST-1495)
Not yet recruiting
- Colorectal Carcinoma (CRC)
- Endometrial Carcinoma (EC)
-
Oklahoma City, OklahomaStephenson's Cancer Center
Nov 8, 2023
Endometrial Cancer, Uterine Cancer Trial in Chapel Hill (Pembrolizumab, Hysterectomy)
Recruiting
- Endometrial Cancer
- Uterine Cancer
- Pembrolizumab
- Hysterectomy
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Sep 27, 2022
NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))
Not yet recruiting
- Non-small Cell Lung Cancer
- Durvalumab
- +2 more
-
Iowa City, IowaUniversity of Iowa
Oct 10, 2023
Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
May 5, 2023
Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)
Not yet recruiting
- Breast Cancer
- +3 more
- (no location specified)
Aug 4, 2023
Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
- Black Raspberry
- (no location specified)
Oct 16, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Imatinib 400 MG Oral Tablet
-
Gothenburg, SwedenBarbro Linderholm
Feb 1, 2023
Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)
Not yet recruiting
- Breast Cancer
- Breast Cancer, Early-Onset
- (no location specified)
Jan 18, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Milwaukee (Antitumor B KAC)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Antitumor B KAC
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jul 6, 2022